References
- US. Package Circular: VAQTA™ (Hepatitis A Vaccine, Inactivated): February 2003
- Centers for Disease Control and Prevention. Prevention of Hepatitis A through Active or Passive Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2006;55(RR07):1-23
- US. Package Circular: Infanrix™ (diphtheria/tetanus/acellular pertussis [DTaP] vaccine; GlaxoSmithKline): July 2012
- US. Package Circular: PedvaxHIB™ (H. influenzae type b [Hib] conjugate vaccine [Meningococcal protein conjugate]; Merck & Co., Inc.): December 2010
- Centers for Disease Control and Prevention. Child, Adolescent & “Catch-up” Immunization Schedules. Available at: http://www.cdc.gov/vaccines/schedules/hcp/child-adolescent.html. Accessed: August 22, 2012
- Guerra FA, Gress J, Werzberger A, Reisinger K, Walter E, Lakkis H, Grosso AD, Welebob C, Kuter BJ; Pediatric Study Group for VAQTA. Safety, tolerability and immunogenicity of VAQTA given concomitantly vs. nonconcomitantly with other pediatric vaccines in healthy 12-month-old children. Pediatr Infect Dis J 2006; 25:912-9; PMID:17006287; http://dx.doi.org/10.1097/01.inf.0000238135.01287.b9
- Nolan T, Bernstein H, Blatter MM, Bromberg K, Guerra F, Kennedy W, Pichichero M, Senders SD, Trofa A, Collard A, et al. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age. Pediatrics 2006; 118:e602-9; PMID:16950952; http://dx.doi.org/10.1542/peds.2005-2755
- Trofa AF, Klein NP, Paul IM, Michaels MG, Goessler M, Chandrasekaran V, Blatter M. Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines in children 15 months of age. Pediatr Infect Dis J 2011; 30:e164-9; PMID:21494175; http://dx.doi.org/10.1097/INF.0b013e31821b8a7d